Loading clinical trials...
Loading clinical trials...
This is a substudy of Study AG348-C-008, an observational, longitudinal, multicenter, global registry that aims to better understand the longitudinal clinical implications of pyruvate kinase deficienc...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Agios Pharmaceuticals, Inc.
NCT05777993 · Pyruvate Kinase Deficiency, Anemia, Hemolytic
NCT05144256 · Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia
NCT03481738 · Pyruvate Kinase Deficiency
NCT04105166 · Pyruvate Kinase Deficiency
NCT02476916 · Pyruvate Kinase Deficiency
Massachusetts General Hospital
Boston, Massachusetts
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico
Milan
Universitair Medisch Centrum Utrecht
Utrecht
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions